50 research outputs found
Diabetic Patients with Cardiovascular Disease Show More Metabolic Syndrome than Nondiabetic Patients: Multicentric Study in the Northeast of Brazil
D 015 Glucose Tolerance Test – Important on the Assessment of the Glicidic Metabolism in Obese Patients with Low HDL Cholesterol
Polypharmacy among adult and older adult users of primary care services delivered through the Unified Health System in Minas Gerais, Brazil
IA 013 Importance of Cardiovascular Risk Factors to Coronary Calcification in Patients with Dyslipidemia and Impaired Fasting Glucose
Acute in vivo chylomicron metabolism and postalimentary lipoprotein alterations in normolipidemic male smokers
Increased postprandial lipemia has been stated as one of the mechanisms responsible for atherogenesis in smokers. We measured the postalimentary lipid response and the in vivo intravascular delipidation index of an artificial chylomicron emulsion in healthy adult smokers and controls. The blood was collected in the fasting state immediately after the smokers smoked one cigarette. The lipemia was measured 2, 4, 6 and 8 h postalimentarily in smokers (S, n=8) and in non-smoking controls (C, n=8) and the chylomicron metabolism rate was measured 2, 4, 6, 8, 12, 16, 20, 24 and 30 min after the injection of an artificial emulsion to S (n= 10) and to C (n=10). The lipoproteins were isolated in the fasting period and 4 h after the fatty meal and their chemical composition in cholesterol, triglycerides, phospholipids and protein was determined. Smokers showed an increased lipolysis percentage value (mean +/-S.E.M) of the artificial chylomicron (39.1 +/-3.1) compared to controls (26.5 +/-3.3) and higher levels of HDL2-PL: 28.4 +/-4.3 (S) versus 16.2 +/-2.0 (C) mg/dl (mean +/-S.E.M.). In conclusion, the oral fat tolerance was not altered in smokers but an upregulation of the rate of metabolism of the TG-rich lipoproteins was elicited immediately after smoking one cigarette. (C) 2001 Elsevier Science B.V. All rights reserved.305416719910
